Complete Filing Data
Relay Therapeutics, Inc. reported Stockholders Equity of $567.06 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Relay Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue * | $15.4M | $10.0M | $25.5M | $1.4M | $3.0M | $82.7M | |
| Net Income Loss | -$276.5M | -$337.7M | -$342.0M | -$290.5M | -$363.9M | -$52.4M | -$75.3M |
| Other Nonoperating Income Expense | $26.3M | $34.8M | $31.0M | $8.8M | $826.0K | $3.4M | $8.7M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | $1.7M | -$795.0K | $10.2M | -$9.3M | -$1.2M | -$261.0K | $325.0K |
| Other Comprehensive Income Loss Net Of Tax | $1.7M | -$795.0K | $10.2M | -$9.3M | -$1.2M | -$261.0K | $325.0K |
| Operating Income Loss | -$302.7M | -$372.5M | -$373.0M | -$299.3M | -$364.7M | -$55.8M | -$84.0M |
| Operating Expenses | $318.1M | $382.5M | $398.5M | $300.7M | $367.7M | $138.5M | $84.0M |
| General And Administrative Expense | $56.7M | $76.6M | $75.0M | $66.0M | $57.4M | $38.6M | $13.7M |
| Comprehensive Income Net Of Tax | -$274.8M | -$338.5M | -$331.7M | -$299.8M | -$365.0M | -$52.7M | -$75.0M |
| Research And Development Expense Excluding Acquired In Process Cost | $261.4M | $319.1M | $330.0M | $246.4M | $172.7M | $99.9M | $70.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $0.00 | $677.0K | $7.7M | $0.00 | $0.00 | $10.0M | $25.2M | $119.0K | $226.0K | $344.0K | $365.0K | $419.0K | $666.0K | $844.0K | $952.0K | ||||||
| Net Income Loss | -$74.1M | -$70.4M | -$77.1M | -$88.1M | -$92.2M | -$81.4M | -$65.7M | -$98.5M | -$94.2M | -$84.2M | -$76.8M | -$62.0M | -$60.8M | -$193.4M | -$42.2M | -$36.1M | -$26.7M | -$24.9M | -$19.7M | -$17.5M | -$14.2M |
| Other Nonoperating Income Expense | $6.2M | $6.5M | $7.8M | $8.3M | $8.5M | $9.0M | $7.8M | $7.5M | $6.9M | $1.7M | $1.0M | $675.0K | $157.0K | $181.0K | $221.0K | $529.0K | $995.0K | $1.6M | $2.2M | $2.4M | |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | $656.0K | -$201.0K | $1.0M | $3.8M | -$182.0K | -$962.0K | $2.7M | -$279.0K | $4.6M | -$1.5M | -$2.7M | -$8.1M | $74.0K | -$76.0K | -$52.0K | -$455.0K | -$763.0K | $1.1M | -$68.0K | $475.0K | |
| Other Comprehensive Income Loss Net Of Tax | $656.0K | -$201.0K | $1.0M | $3.8M | -$182.0K | -$962.0K | $2.7M | -$279.0K | $4.6M | -$1.5M | -$2.7M | -$8.1M | $74.0K | -$76.0K | -$52.0K | -$455.0K | -$763.0K | $1.1M | -$68.0K | $475.0K | |
| Operating Income Loss | -$80.4M | -$76.8M | -$84.9M | -$96.4M | -$100.8M | -$90.4M | -$73.6M | -$106.1M | -$101.2M | -$85.9M | -$77.8M | -$62.7M | -$61.0M | -$193.6M | -$42.4M | -$36.6M | -$27.7M | -$26.5M | -$21.9M | -$19.9M | |
| Operating Expenses | $80.4M | $77.5M | $92.5M | $96.4M | $100.8M | $100.4M | $98.8M | $106.2M | $101.4M | $86.2M | $78.2M | $63.1M | $61.7M | $194.4M | $43.4M | $36.6M | $27.7M | $26.5M | $21.9M | $19.9M | |
| General And Administrative Expense | $12.1M | $13.6M | $18.7M | $19.8M | $20.1M | $19.8M | $18.5M | $20.1M | $19.6M | $16.1M | $17.5M | $16.1M | $14.7M | $14.4M | $12.7M | $12.2M | $6.1M | $4.8M | $3.7M | $3.5M | |
| Comprehensive Income Net Of Tax | -$73.5M | -$70.6M | -$76.0M | -$84.3M | -$92.4M | -$82.3M | -$63.0M | -$98.8M | -$89.6M | -$85.7M | -$79.5M | -$70.2M | -$60.8M | -$193.5M | -$42.2M | -$36.5M | -$27.5M | -$23.8M | -$19.7M | -$17.1M | |
| Research And Development Expense Excluding Acquired In Process Cost | $68.3M | $63.9M | $73.8M | $76.6M | $92.0M | $82.4M | $81.5M | $88.2M | $82.8M | $66.9M | $60.5M | $51.7M | $45.0M | $45.1M | $30.6M | $24.4M | $21.7M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $567.1M | $777.8M | $752.0M | $950.2M | $897.8M | $763.3M | -$180.4M | -$110.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $85.4M | $126.4M | $146.4M | $154.4M | $282.7M | $448.5M | $42.8M | $422.4M |
| Cash And Cash Equivalents At Carrying Value | $84.0M | $124.3M | $143.7M | $151.8M | $280.1M | $447.6M | $42.0M | |
| Debt Securities Available For Sale Unrealized Gain Loss | $1.7M | -$795.0K | $10.2M | -$9.3M | -$1.2M | -$261.0K | ||
| Restricted Cash | $1.3M | $2.1M | $2.7M | $2.6M | $2.6M | $878.0K | $878.0K | |
| Business Combination Contingent Consideration Liability | $0.00 | $13.2M | $32.4M | $50.3M | $0.00 | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$41.1M | -$20.0M | -$7.9M | -$128.3M | -$165.8M | $405.7M | -$379.6M | |
| Accretion Amortization Of Discounts And Premiums Investments | $4.9M | $12.3M | $10.8M | -$1.2M | -$2.1M | $416.0K | $2.5M | |
| Retained Earnings Accumulated Deficit | -$2.01B | -$1.74B | -$1.40B | -$1.06B | -$768.1M | -$404.2M | -$189.5M | |
| Property Plant And Equipment Net | $1.7M | $5.9M | $10.9M | $11.6M | $6.5M | $6.3M | $8.1M | |
| Operating Lease Right Of Use Asset | $40.0M | $51.8M | $58.0M | $63.8M | $20.8M | $22.6M | $23.6M | |
| Operating Lease Liability Noncurrent | $28.7M | $42.8M | $48.5M | $53.5M | $21.1M | $22.9M | $23.6M | |
| Operating Lease Liability Current | $3.8M | $5.7M | $5.0M | $4.3M | $1.8M | $1.5M | $1.2M | |
| Liabilities Current | $25.6M | $50.7M | $30.3M | $63.7M | $24.3M | $13.6M | $12.0M | |
| Liabilities And Stockholders Equity | $621.3M | $871.3M | $844.0M | $1.10B | $1.01B | $799.8M | $393.1M | |
| Liabilities | $54.3M | $93.5M | $92.0M | $149.6M | $110.6M | $36.5M | $35.7M | |
| Investments | $470.5M | $657.0M | $606.4M | $847.1M | $678.0M | $230.4M | $313.9M | |
| Assets Current | $578.3M | $809.2M | $770.1M | $1.02B | $976.2M | $770.1M | $360.5M | |
| Assets | $621.3M | $871.3M | $844.0M | $1.10B | $1.01B | $799.8M | $393.1M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $733.0K | -$991.0K | -$196.0K | -$10.4M | -$1.1M | $64.0K | $325.0K | |
| Accrued Liabilities Current | $13.6M | $21.2M | $14.9M | $22.7M | $13.6M | $5.8M | $3.7M | |
| Accounts Payable Current | $7.7M | $14.1M | $9.2M | $10.6M | $8.3M | $6.4M | $7.0M | |
| Change In Fair Value Of Contingent Consideration Liabilities | -$13.2M | -$6.4M | -$11.7M | $2.8M | ||||
| Restricted Cash Noncurrent | $1.3M | $2.1M | $2.7M | $2.6M | $2.6M | $878.0K | $878.0K | |
| Common Stock Value | $168.0K | $168.0K | $127.0K | $121.0K | $109.0K | $90.0K | ||
| Other Liabilities Current | $463.0K | $2.0M | $1.2M | $26.2M | $396.0K | |||
| Vesting Of Restricted Common Stock Value | $3.0K | $154.0K | $400.0K | |||||
| Other Assets Current | $6.0M | $10.5M | $3.3M | $3.3M | $1.8M | |||
| Finite Lived Intangible Assets Net | $2.3M | $2.3M | ||||||
| Accounts Receivable Net Current | $306.0K | $403.0K | $75.0M | |||||
| Reclassification Of Restricted Stock Liability To Additional Paid In Capital | $3.0K | $153.0K | $400.0K | |||||
| Prepaid Expense And Other Assets Current | $9.4M | $4.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $607.7M | $665.7M | $721.1M | $838.9M | $681.7M | $745.8M | $778.4M | $810.1M | $883.4M | $999.8M | $779.6M | $842.0M | $571.1M | $618.5M | $732.8M | $713.5M | -$225.4M | -$202.4M | -$158.3M | -$140.0M | -$124.2M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $93.8M | $116.2M | $95.7M | $154.5M | $136.8M | $155.6M | $154.0M | $148.6M | $163.9M | $357.2M | $110.3M | $122.0M | $231.1M | $262.6M | $263.6M | $560.2M | $137.9M | $71.2M | $29.9M | $40.2M | |||
| Cash And Cash Equivalents At Carrying Value | $91.6M | $113.9M | $93.5M | $152.4M | $134.1M | $152.9M | $151.3M | $145.9M | $161.3M | $354.6M | $107.7M | $119.4M | $228.6M | $260.1M | $262.7M | $559.3M | $137.1M | $70.3M | $29.0M | $39.4M | |||
| Debt Securities Available For Sale Unrealized Gain Loss | $656.0K | -$201.0K | $1.0M | $3.8M | -$182.0K | -$962.0K | $2.7M | -$279.0K | $4.6M | -$1.5M | -$2.7M | -$8.1M | $74.0K | -$76.0K | -$52.0K | ||||||||
| Restricted Cash | $2.3M | $2.3M | $2.1M | $2.1M | $2.7M | $2.7M | $2.7M | $2.7M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $878.0K | $878.0K | $878.0K | $878.0K | $878.0K | $878.0K | |||
| Business Combination Contingent Consideration Liability | $0.00 | $11.4M | $28.0M | $29.2M | $31.4M | $42.9M | $45.9M | $45.7M | $50.5M | $48.5M | |||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$30.7M | $9.1M | $9.5M | -$160.7M | -$184.9M | $28.4M | |||||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $1.6M | $3.7M | $2.0M | -$681.0K | -$153.0K | $321.0K | |||||||||||||||||
| Retained Earnings Accumulated Deficit | -$1.96B | -$1.89B | -$1.82B | -$1.66B | -$1.57B | -$1.48B | -$1.32B | -$1.25B | -$1.15B | -$991.1M | -$906.9M | -$830.1M | -$700.6M | -$639.8M | -$446.4M | -$439.5M | -$241.1M | ||||||
| Property Plant And Equipment Net | $2.4M | $3.5M | $5.1M | $7.2M | $8.4M | $9.9M | $10.7M | $11.7M | $12.0M | $11.4M | $8.9M | $8.9M | $6.2M | $6.6M | $5.9M | $6.6M | $7.4M | ||||||
| Operating Lease Right Of Use Asset | $41.4M | $42.7M | $50.1M | $53.4M | $54.9M | $56.5M | $59.5M | $60.9M | $62.3M | $65.2M | $19.8M | $20.3M | $21.2M | $21.7M | $22.1M | $22.4M | $22.8M | ||||||
| Operating Lease Liability Noncurrent | $29.7M | $30.7M | $41.2M | $44.3M | $45.8M | $47.2M | $49.8M | $51.1M | $52.3M | $54.6M | $20.0M | $20.6M | $21.5M | $22.0M | $22.5M | $22.5M | $22.9M | ||||||
| Operating Lease Liability Current | $3.6M | $3.5M | $5.9M | $5.5M | $5.3M | $5.1M | $4.8M | $4.6M | $4.4M | $5.7M | $2.0M | $1.9M | $1.8M | $1.7M | $1.6M | $1.4M | $1.4M | ||||||
| Liabilities Current | $32.6M | $32.5M | $37.1M | $47.0M | $45.0M | $37.1M | $50.7M | $71.6M | $70.5M | $71.4M | $43.9M | $41.7M | $28.5M | $25.4M | $16.1M | $15.7M | $12.8M | ||||||
| Liabilities And Stockholders Equity | $670.0M | $728.8M | $799.4M | $930.1M | $772.6M | $841.4M | $907.0M | $962.0M | $1.04B | $1.17B | $889.4M | $949.9M | $671.6M | $714.4M | $771.3M | $751.7M | $348.0M | ||||||
| Liabilities | $62.3M | $63.2M | $78.3M | $91.3M | $90.8M | $95.7M | $128.6M | $151.9M | $154.1M | $168.9M | $109.8M | $107.9M | $100.5M | $95.9M | $38.6M | $38.2M | $35.6M | ||||||
| Investments | $504.9M | $542.8M | $616.8M | $687.3M | $554.3M | $596.7M | $659.3M | $725.7M | $776.5M | $699.1M | $730.3M | $778.7M | $387.9M | $411.2M | $463.4M | $154.2M | $175.2M | ||||||
| Assets Current | $624.0M | $680.4M | $739.7M | $865.1M | $704.3M | $770.1M | $831.8M | $884.3M | $958.4M | $1.09B | $855.8M | $915.8M | $639.3M | $681.3M | $742.4M | $721.9M | $315.9M | ||||||
| Assets | $670.0M | $728.8M | $799.4M | $930.1M | $772.6M | $841.4M | $907.0M | $962.0M | $1.04B | $1.17B | $889.4M | $949.9M | $671.6M | $714.4M | $771.3M | $751.7M | $348.0M | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $493.0K | -$163.0K | $38.0K | $2.5M | -$1.3M | -$1.2M | -$3.4M | -$6.1M | -$5.8M | -$13.4M | -$11.9M | -$9.2M | $10.0K | -$64.0K | $12.0K | $176.0K | $631.0K | ||||||
| Accrued Liabilities Current | $25.1M | $23.2M | $21.0M | $33.2M | $27.8M | $22.4M | $31.5M | $26.9M | $28.0M | $29.4M | $22.1M | $15.2M | $20.1M | $15.4M | $8.9M | $9.7M | $8.6M | ||||||
| Accounts Payable Current | $2.8M | $5.2M | $8.5M | $6.9M | $11.2M | $8.0M | $13.4M | $14.8M | $11.8M | $9.5M | $4.3M | $8.1M | $6.3M | $7.9M | $5.6M | $4.6M | $2.8M | ||||||
| Change In Fair Value Of Contingent Consideration Liabilities | $0.00 | $0.00 | $0.00 | -$11.4M | -$1.8M | -$1.2M | -$2.2M | -$1.0M | $3.3M | $200.0K | -$4.6M | $2.0M | |||||||||||
| Restricted Cash Noncurrent | $2.3M | $2.3M | $2.1M | $2.1M | $2.7M | $2.7M | $2.7M | $2.7M | $2.6M | $2.6M | $2.6M | $2.6M | |||||||||||
| Common Stock Value | $168.0K | $168.0K | $168.0K | $167.0K | $133.0K | $132.0K | $123.0K | $122.0K | $121.0K | $121.0K | $109.0K | $109.0K | |||||||||||
| Other Liabilities Current | $1.1M | $609.0K | $1.7M | $1.4M | $768.0K | $1.7M | $1.1M | $25.3M | $26.1M | $26.9M | $15.4M | $16.3M | |||||||||||
| Vesting Of Restricted Common Stock Value | $3.0K | $5.0K | $47.0K | $98.0K | $98.0K | $100.0K | $101.0K | ||||||||||||||||
| Other Assets Current | $3.7M | $7.6M | $7.4M | $6.8M | $5.7M | $7.3M | $3.7M | $3.4M | $4.1M | $11.6M | |||||||||||||
| Finite Lived Intangible Assets Net | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | |||||||||||
| Accounts Receivable Net Current | $211.0K | $78.0K | $286.0K | $241.0K | $288.0K | $269.0K | $804.0K | $279.0K | |||||||||||||||
| Reclassification Of Restricted Stock Liability To Additional Paid In Capital | $3.0K | $98.0K | |||||||||||||||||||||
| Prepaid Expense And Other Assets Current | $12.8M | $12.7M | $13.2M | $17.7M | $5.6M | $7.8M | $8.4M | $3.7M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $62.4M | $94.1M | $86.0M | $56.1M | $48.5M | $32.0M | $4.5M |
| Proceeds From Sale And Maturity Of Other Investments | $316.2M | $611.6M | $647.3M | $355.7M | $529.9M | $350.1M | $242.5M |
| Payments To Acquire Property Plant And Equipment | $410.0K | $2.0M | $4.1M | $9.1M | $3.5M | $1.9M | $8.0M |
| Payments To Acquire Investments | $123.0M | $650.6M | $385.5M | $535.4M | $980.7M | $266.5M | $553.5M |
| Net Cash Provided By Used In Operating Activities | -$235.5M | -$249.1M | -$300.3M | -$229.5M | -$74.4M | -$102.5M | -$66.1M |
| Net Cash Provided By Used In Investing Activities | $192.8M | -$41.1M | $257.6M | -$188.7M | -$479.5M | $81.7M | -$319.0M |
| Increase Decrease In Prepaid Expense | -$1.6M | $5.4M | $4.6M | $2.1M | $2.7M | $4.7M | $2.1M |
| Net Cash Provided By Used In Financing Activities | $1.6M | $270.2M | $34.8M | $289.9M | $388.1M | $426.5M | $5.6M |
| Increase Decrease In Operating Lease Assets And Liabilities Net | $4.3M | -$1.2M | -$1.5M | $8.1M | -$277.0K | -$571.0K | -$1.2M |
| Increase Decrease In Accrued Liabilities | -$32.1M | $20.1M | $21.0M | $2.0M | $2.2M | ||
| Increase Decrease In Accounts Payable | -$2.4M | $2.0M | $930.0K | -$410.0K | $3.0M | ||
| Increase Decrease In Commodity Contract Assets And Liabilities | -$4.9M | $376.0K | -$3.1M | $7.7M | |||
| Increase Decrease In Accounts Receivable | -$306.0K | -$97.0K | -$74.7M | $75.0M | |||
| Proceeds From Issuance Of Common Stock Upon Exercise Of Stock Options | $2.0M | $3.5M | $4.7M | $1.2M | |||
| Proceeds From Issuance Of Common Stock | $4.7M | $1.2M | $613.0K | ||||
| Increase Decrease In Deferred Revenue | -$7.7M | $7.7M | -$248.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $19.3M | $27.2M | $21.5M | $13.5M | $9.7M | $1.5M |
| Proceeds From Sale And Maturity Of Other Investments | $64.8M | $203.1M | $175.0M | $18.1M | $386.2M | $107.0M |
| Payments To Acquire Property Plant And Equipment | $384.0K | $1.8M | $1.9M | $2.8M | $476.0K | $1.0M |
| Payments To Acquire Investments | $22.0M | $190.8M | $97.8M | $127.7M | $619.3M | $55.6M |
| Net Cash Provided By Used In Operating Activities | -$73.2M | -$50.3M | -$67.1M | -$49.2M | $46.6M | -$22.3M |
| Net Cash Provided By Used In Investing Activities | $42.5M | $10.5M | $75.3M | -$112.4M | -$233.6M | $50.4M |
| Increase Decrease In Prepaid Expense | $3.9M | $475.0K | -$16.0K | -$566.0K | -$1.6M | -$261.0K |
| Net Cash Provided By Used In Financing Activities | $48.9M | $1.3M | $883.0K | $2.1M | $351.0K | |
| Increase Decrease In Operating Lease Assets And Liabilities Net | -$283.0K | -$350.0K | -$415.0K | -$48.0K | -$130.0K | |
| Increase Decrease In Accrued Liabilities | $8.0M | $5.6M | $3.1M | $3.1M | $2.5M | |
| Increase Decrease In Accounts Payable | $102.0K | $1.4M | -$1.2M | -$811.0K | -$2.3M | |
| Increase Decrease In Commodity Contract Assets And Liabilities | $32.0K | $140.0K | $952.0K | |||
| Increase Decrease In Accounts Receivable | -$20.0K | -$134.0K | -$75.0M | |||
| Proceeds From Issuance Of Common Stock Upon Exercise Of Stock Options | $1.2M | $1.3M | $883.0K | |||
| Proceeds From Issuance Of Common Stock | $883.0K | $2.1M | $351.0K | |||
| Increase Decrease In Deferred Revenue | -$7.7M | -$82.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.61 | -$2.36 | -$2.79 | -$2.59 | -$3.82 | -$5.40 | -$21.82 |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 150.0M | 150.0M | 260.0M |
| Weighted Average Number Of Shares Outstanding Basic | 171.6M | 142.9M | 122.6M | 112.2M | 95.1M | 42.6M | |
| Earnings Per Share Basic | $-1.61 | $-2.36 | $-2.79 | $-2.59 | $-3.82 | $-5.40 | |
| Common Stock Shares Outstanding | 173.9M | 167.8M | 127.5M | 121.1M | 108.2M | 89.9M | 4.0M |
| Common Stock Shares Issued | 173.9M | 167.8M | 127.5M | 121.1M | 108.2M | 90.0M | 4.7M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Diluted | 171.6M | 142.9M | 122.6M | 112.2M | 95.1M | 42.6M | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 95.1M | 42.6M | 3.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.43 | -$0.41 | -$0.46 | -$0.63 | -$0.69 | -$0.62 | -$0.54 | -$0.81 | -$0.78 | -$0.76 | -$0.71 | -$0.57 | -$0.66 | -$2.10 | -$0.47 | -$3.00 | -$6.06 | -$5.99 | -$5.53 | -$5.28 |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | ||||
| Weighted Average Number Of Shares Outstanding Basic | 172.4M | 171.3M | 169.2M | 140.2M | 132.8M | 130.8M | 122.2M | 121.7M | 121.3M | 110.9M | 108.6M | 108.3M | 92.7M | |||||||
| Earnings Per Share Basic | $-0.43 | $-0.41 | $-0.46 | $-0.63 | $-0.69 | $-0.62 | $-0.54 | $-0.81 | $-0.78 | $-0.76 | $-0.71 | $-0.57 | $-0.66 | |||||||
| Common Stock Shares Outstanding | 172.6M | 171.7M | 170.5M | 166.9M | 133.3M | 132.3M | 123.2M | 121.9M | 121.5M | 120.8M | 108.8M | 108.4M | 92.8M | 92.6M | 90.4M | 89.8M | 4.6M | |||
| Common Stock Shares Issued | 172.6M | 171.7M | 170.5M | 166.9M | 133.3M | 132.3M | 123.2M | 121.9M | 121.5M | 120.8M | 108.8M | 108.4M | 92.8M | 92.6M | 90.4M | 90.0M | 4.9M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Shares Outstanding Diluted | 172.4M | 171.3M | 169.2M | 140.2M | 132.8M | 130.8M | 122.2M | 121.7M | 121.3M | 110.9M | 108.6M | 108.3M | ||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 108.6M | 108.3M | 92.7M | 91.9M | 90.2M | 71.2M | 4.4M | 4.2M | 3.6M | 3.3M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $62.4M | $94.1M | $86.0M | $56.1M | $48.5M | $32.0M | $4.5M |
| Stock Issued During Period Value Stock Options Exercised | $524.0K | $2.8M | $2.0M | $3.5M | $4.7M | $1.2M | $613.0K |
| Interest Income Other | $27.0M | $34.7M | $31.0M | $8.8M | $830.0K | $3.4M | $8.8M |
| Other Income Expense | -$776.0K | $14.0K | -$18.0K | -$20.0K | -$4.0K | -$16.0K | |
| Depreciation | $3.6M | $5.5M | $5.3M | $4.1M | $3.9M | $3.5M | $2.8M |
| Additional Paid In Capital | $2.58B | $2.52B | $2.15B | $2.02B | $1.67B | $1.17B | $8.7M |
| Prepaid Expense Current | $17.8M | $17.3M | $16.7M | $12.1M | $11.5M | ||
| Stock Issued During Period Value Employee Stock Purchase Plan | $1.1M | $1.5M | $2.5M | $1.7M | $1.1M | ||
| Contract With Customer Asset Net | $4.9M | $4.5M | $7.7M | ||||
| Capital Expenditures Incurred But Not Yet Paid | $159.0K | $1.0M | $519.0K | $745.0K | |||
| Stock Issued During Period Value New Issues | $30.3M | $284.7M | $382.2M | $425.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $15.5M | $14.5M | $19.3M | $22.5M | $26.8M | $27.2M | $21.8M | $23.4M | $21.5M | $13.7M | $15.1M | $13.5M | $12.4M | $16.1M | $9.7M | $11.9M | $4.0M | $1.5M | $1.2M | $1.1M | $820.0K |
| Stock Issued During Period Value Stock Options Exercised | $17.0K | $732.0K | $413.0K | $1.2M | $95.0K | $453.0K | $1.3M | $1.1M | $859.0K | $883.0K | $900.0K | $1.1M | $2.1M | $442.0K | $367.0K | $351.0K | $120.0K | $23.0K | $29.0K | ||
| Interest Income Other | $6.4M | $7.1M | $7.8M | $8.3M | $8.5M | $9.0M | $7.8M | $7.6M | $6.9M | $1.7M | $1.0M | $696.0K | $157.0K | $180.0K | $226.0K | $534.0K | $998.0K | $1.6M | $2.2M | $2.4M | |
| Other Income Expense | -$165.0K | -$633.0K | -$9.0K | -$10.0K | -$2.0K | $25.0K | -$2.0K | -$14.0K | -$3.0K | $7.0K | $18.0K | -$21.0K | $1.0K | -$5.0K | -$5.0K | -$3.0K | |||||
| Depreciation | $1.2M | $1.4M | $1.2M | $975.0K | $919.0K | $859.0K | |||||||||||||||
| Additional Paid In Capital | $2.57B | $2.55B | $2.54B | $2.50B | $2.26B | $2.23B | $2.10B | $2.07B | $2.04B | $2.00B | $1.70B | $1.68B | $1.27B | $1.26B | $1.18B | $1.15B | $15.1M | ||||
| Prepaid Expense Current | $23.8M | $16.0M | $22.0M | $18.7M | $10.1M | $13.2M | $17.3M | $9.3M | $11.3M | $16.8M | |||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $653.0K | $732.0K | $1.1M | $1.6M | $1.1M | ||||||||||||||||
| Contract With Customer Asset Net | $4.9M | $4.9M | $4.8M | $4.7M | $4.3M | $4.2M | $8.6M | ||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $1.6M | $100.0K | $51.0K | ||||||||||||||||||
| Stock Issued During Period Value New Issues | $9.4M | $284.7M | $425.3M |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.